Follow The Filings

DKNG Draftkings Inc.

Consumer Discretionary, filed as DRAFTKINGS INC NEW (COM CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 4 Owners
  • Max 7.2%
  • $390M
  • 1 new 2 reduce

In 2026 Q2 Davidson Kempner Capital Management opened a position in Draftkings, while Cathie Wood and Ron Baron trimmed.

Who owns this now

Largest portfolio weights among holders, up to 7.2% (Ben Tsai, Spruce House Investment Management). Not free-float ownership.

  1. Ben Tsai 7.2%
  2. Davidson Kempner Capital Mana... New 0.23%
  3. Cathie Wood Reduce 0.20%
  4. Ron Baron Reduce 0.14%

Who owns DKNG

Sorted by value, long equity only, as of 2026 Q2.

History
Ben Tsai, Spruce House Investment Management 7.2% Hold 9,650,000 $244M History
Ron Baron, Bamco Inc. (Baron Capital) 0.14%, was 0.27% Reduce −10.7% 3,768,624 $95M History
Cathie Wood, Ark Investment Management 0.20%, was 0.23% Reduce −9.2% 1,228,846 $31M History
Davidson Kempner Capital Management 0.23% New 0.23% 779,805 $20M History

4 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DKNG's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DKNG insider trades
  • $3.2M bought by 2 insiders
  • $880K sold by 1 insider outside a trading plan
  • $19.9M sold by 5 insiders under 10b5-1 plans
  1. Jocelyn Moore Director
    Planned sale
    $259K 10,759 shares at $24.05 85% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  2. R Stanton Dodge Chief Legal Officer
    Planned sale
    $1.9M 62,500 shares at $29.68 10% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  3. Erik Bradbury Chief Accounting Officer
    Planned sale
    $22K 862 shares at $25.33 2.2% of stake
    Traded May 20 Filed May 22
    ↗
  4. Woodrow Levin Director
    Sale
    $880K 34,234 shares at $25.71 53% of stake
    Traded May 18 Filed May 19
    ↗
  5. Jocelyn Moore Director
    Planned sale
    $55K 2,150 shares at $25.60 61% of stake
    Traded Mar 13 Filed Mar 16
    ↗
  6. Paul Liberman See Remarks
    Planned sale
    $12.2M 484,417 shares at $25.16 69% of stake
    Traded Mar 11 Filed Mar 12
    ↗
  7. Erik Bradbury Chief Accounting Officer
    Planned sale
    $71K 2,883 shares at $24.56 7% of stake
    Traded Mar 3 Filed Mar 3
    ↗
  8. Erik Bradbury Chief Accounting Officer
    Planned sale
    $164K 7,268 shares at $22.50 17% of stake
    Traded Feb 19 Filed Feb 20
    ↗
  9. Harry Sloan Director
    Buy
    $2.2M 100,000 shares at $21.85 +40% to stake
    Traded Feb 17 Filed Feb 18
    ↗
  10. R Stanton Dodge Chief Legal Officer
    Planned sale
    $1.7M 52,777 shares at $32.01 9.5% of stake
    Traded Jan 20 Filed Jan 22
    ↗
  11. R Stanton Dodge Chief Legal Officer
    Planned sale
    $1.8M 52,777 shares at $33.84 9.3% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
    ↗
  12. Alan Wayne Ellingson CFO
    Planned sale
    $246K 8,421 shares at $29.23 6.2% of stake
    Traded Nov 14, 2025 Filed Nov 14, 2025
    ↗
  13. Gregory Westin Wendt Director
    Buy
    $303K 10,000 shares at $30.27 New stake
    Traded Nov 11, 2025 Filed Nov 12, 2025
    ↗
  14. Harry Sloan Director
    Buy
    $758K 25,000 shares at $30.30 +11% to stake
    Traded Nov 11, 2025 Filed Nov 12, 2025
    ↗
  15. R Stanton Dodge Chief Legal Officer
    Planned sale
    $1.5M 52,777 shares at $29.00 9.5% of stake
    Traded Nov 6, 2025 Filed Nov 7, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 131 option exercises, 103 share withholdings for taxes, 6 stock grants, 6 gifts, and 1 other transaction.

Congress

No member of Congress reported trading DKNG in the last three years. 2 members listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 4.01,9.01 Filing Doc
8-K 1.01,2.03,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01 Filing Doc
8-K 7.01 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $4.77B $6.05B
Gross profit * — $1.82B $2.5B
Gross margin * — 38.1% 41.3%
Net income -$802.14M -$507.28M $3.71M
Net margin * — -10.6% 0.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.07B $1.53B $1.82B
Total non-current assets * $1.87B $2.75B $2.72B
Total assets $3.94B $4.28B $4.53B
Total current liabilities $1.55B $1.65B $1.76B
Total non-current liabilities * $1.55B $1.62B $2.14B
Total equity $0.84B $1.01B $0.631B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.75M $417.77M $662.86M
Cash from investing -$90.36M -$566.6M -$166M
Cash from financing -$63.22M -$144.47M -$222.46M
Net change in cash -$155.33M -$293.3M $274.4M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.